Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Johnson & Johnson : Thinking about trading options or stock in AbbVie, Bristol-Myers Squibb, Goldman Sachs, Johnson & Johnson, or Micron Technology?

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/12/2019 | 09:32am EDT

NEW YORK, Aug. 12, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ABBV, BMY, GS, JNJ, and MU.

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

Cision
View original content:http://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-abbvie-bristol-myers-squibb-goldman-sachs-johnson--johnson-or-micron-technology-300899954.html

SOURCE InvestorsObserver


© PRNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on JOHNSON & JOHNSON
09/19JOHNSON & JOHNSON : Janssen to Highlight Depth of Prostate Cancer and Solid Tumo..
PU
09/19JOHNSON & JOHNSON : U.S. FDA Approves Supplemental New Drug Application (sNDA) f..
PU
09/18JOHNSON & JOHNSON : to Host Investor Conference Call on Third Quarter Results
PR
09/18THE LATEST : J&J company says it will fight WVa mesh lawsuit
AQ
09/18JOHNSON & JOHNSON : - U.S. FDA Approves Supplemental New Drug Application for ER..
AQ
09/17JOHNSON & JOHNSON : Janssen to Highlight Depth of Prostate Cancer and Solid Tumo..
PU
09/17JOHNSON & JOHNSON : Janssen Submits Application to U.S. FDA Seeking First-in-Cla..
AQ
09/16JOHNSON & JOHNSON : Janssen Submits Application to U.S. FDA Seeking First-in-Cla..
PU
09/16JOHNSON & JOHNSON : Vision Introduces TECNIS Synergy™ IOL, a Continuous-Ra..
PU
09/16JOHNSON & JOHNSON : - New DARZALEX Data from GRIFFIN Study Show High Response Ra..
AQ
More news